Skip To Main Content
June CH on Muck Rack

June CH

As seen in: Oxford University Press (OUP), PeerJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to June CH’s profile

Articles by June CH

Tertiary lymphoid structures-driven immune infiltration patterns and their association with survival in neuroblastoma

|
By Craig BT, June CH, Skaarup Larsen M, Hank JA
| PeerJ
Tertiary lymphoid structures-driven immune infiltration patterns and their association with survival in neuroblastoma 1Department of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, China 2Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, China 3Department of Pediatric Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer,...
Open in Who Shared Issue with article?

CD4+CD25+ regulatory T cell therapy in neurological autoimmune diseases

|
By Bassel-Duby R, Lee MR, June CH, Scott DW
| PeerJ
The authors declare there are no competing interests. Guobin Yuan conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft. Ying Liu conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.
Open in Who Shared Issue with article?

CAR T therapy beyond cancer: the evolution of a living drug

|
By Baker DJ, Baur JA, Epstein JA, June CH
| nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (490) Issue with article?

T-cell Therapies Targeting Multiple Cancer Antigens: The Power of Many

|
By June CH
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (666) Issue with article?

OPA1 supports mitochondrial dynamics and immune evasion to CD8+ T cell in lung adenocarcinoma

|
By June CH, Kim HK, Lee JI, Elliott KJ
| PeerJ
Additional Information and Declarations Competing Interests No potential conflicts of interest relevant to this article were reported. Xiaoxuan Wang participated in the collation of some data and pictures in our study, who is employed by Jiangsu Simcere Diagnostics Co., Ltd., and also declared there are no competing interests. Author Contributions Ying Wang conceived and designed the experiments, analyzed the data, authored or reviewed drafts of the article, and approved the final draft.
Open in Who Shared Issue with article?

How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies

|
By Of Washington, of Mary Washington, Lee DW, June CH, Kernan NA
| Ash Publications
HOW I TREAT| August 20, 2020 You do not currently have access to this content.
Open in Who Shared View Duplicates (3) Issue with article?

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

|
By Marty FM, June CH
| Ash Publications
Letter to Blood| July 23, 2020 You do not currently have access to this content.
Open in Who Shared Issue with article?

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

|
By Of Wisconsin, of Madison Wisconsin, Of Washington, of Mary Washington, June CH
| Ash Publications
Letters to Blood| July 2, 2020
Open in Who Shared Issue with article?

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

|
By June CH, Lee DW
| Ash Publications
Letter to Blood| June 25, 2020 You do not currently have access to this content.
Open in Who Shared View Duplicates (2) Issue with article?

Using erythrocyte tools to enhance CAR T cells

|
By M. D. Boulet. Eric, of Colorado Anschutz, June CH, Ross ME
| Ash Publications
Immunobiology and Immunotherapy| February 27, 2020
Open in Who Shared Issue with article?

Beat pediatric ALL MRD: CD28 CAR T and transplant

|
By June CH, Kernan NA, Lee DW III, Olson NE
| Ash Publications
Clinical Trials and Observations| December 26, 2019
Open in Who Shared Issue with article?

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

|
By Columbia, June CH, Lee DW, Bender Ignacio
| Ash Publications
IMMUNOBIOLOGY AND IMMUNOTHERAPY| November 19, 2019
Open in Who Shared Issue with article?

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

|
By Kyoto Prefectural, Allison JP, June CH, Joyce JA
| Oxford University Press (OUP)
In patients with advanced or metastatic bladder cancer, first-line therapy is platinum-based therapy including conventional and dose-dense Methotrexate, Vinblastine, Doxorubicin and Cisplatin (M-VAC) or Gemcitabine and Cisplatin (GC) [1–3]. After the first-line treatment, there is no established treatment, while vinflunine is approved in some European countries as a second-line treatment [1, 4].
Open in Who Shared Issue with article?
Show More